GLOMERULONEPHRITIS
Clinical trials for GLOMERULONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new GLOMERULONEPHRITIS trials appear
Sign up with your email to follow new studies for GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early trial tests 'Living Drug' for Tough-to-Treat kidney autoimmunity
Disease control Recruiting nowThis early-stage study is testing the safety and early effectiveness of a new cell therapy called NKX019 for people with active lupus nephritis or primary membranous nephropathy, two serious autoimmune kidney diseases. Participants will receive a one-time treatment cycle involvin…
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Kidney disease drug faces Long-Term safety test
Disease control Recruiting nowThis study follows patients who previously participated in zigakibart trials to monitor long-term safety and effectiveness for IgA nephropathy, a chronic kidney disease. About 220 adults will receive the drug every two weeks for up to two years while researchers track side effect…
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC